NCT02838680View on ClinicalTrials.gov

Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Feasibility Trial CANADA

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

April 9, 2018

Study Completion Date

October 31, 2022

Conditions
Aortic Valve Stenosis
Interventions
DEVICE

HLT Transcatheter Aortic Valve System

Transcatheter aortic valve replacement with HLT Transcatheter Aortic Valve System

Trial Locations (2)

M4N 3M5

Sunnybrook Health Sciences Center, Toronto

G1V 4G5

Institut Universitaire de Cardiologie et de Pneumologie de Québec - Université Laval, Québec

Sponsors

Lead Sponsor

HLT Inc.
All Listed Sponsors
lead

HLT Inc.

INDUSTRY

NCT02838680 - Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Feasibility Trial CANADA | Biotech Hunter | Biotech Hunter